Trials / Completed
CompletedNCT02139319
Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 25 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the safety and tolerability of the drug product at each dose level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum toxin | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2014-05-15
- Last updated
- 2022-08-25
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02139319. Inclusion in this directory is not an endorsement.